Boston Scientific Faces AXIOS Recall And US$11b Penumbra Deal Shift

Boston Scientific (NYSE:BSX) announced a Class I recall of its AXIOS Stent and Electrocautery-Enhanced Delivery Systems due ...
Medical Device and Diagnostic Industry (MD+DI)

Boston Scientific Pulls Select Stents, Electrocautery-Enhanced Delivery Systems

Boston Scientific has issued an FDA warning letter recommending removal of 1,660 lots of AXIOS Stent and Electrocautery Enhanced Delivery Systems due to increased reports of stent deployment and ...

Boston Scientific Halts Use Of Select Stent Delivery Devices After Patient Deaths

Boston Scientific Corp BSX on Wednesday initiated the removal of certain AXIOS Stents and Electrocautery-Enhanced Delivery Systems from clinical settings following reports of deployment complications ...
Becker's Hospital Review

FDA flags safety risk with Boston Scientific stents

FDA flags safety risk with Boston Scientific stents after reports of deployment issues causing deaths and injuries, prompting a Class I recall.
Benzinga.com

Boston Scientific Advises Removal Of Certain AXIOS Stents After Deployment Issues Surface

The U.S. Food and Drug Administration (FDA) said it is aware that Boston Scientific Corporation (NYSE: BSX) has alerted customers to remove certain AXIOS stents and electrocautery-enhanced delivery ...